ABD Blog Reading the Risks for Biotech SPAC IPOs

Despite the disruptions, in both everyday life and the financial markets, caused by the COVID-19 pandemic that began in early 2020, IPO activity has remained strong. During the early stages of the pandemic, we witnessed a halt to public deal flow, However, over the past several months, we have seen the market come back strong. [...]The post Blog first appeared on ABD Insurance & Financial Services.